Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity.
Saved in:
| Title: | Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity. |
|---|---|
| Authors: | Pei X; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Shao W; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Xing A; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Askew C; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Chen X; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Cui C; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Abajas YL; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Gerber DA; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Merricks EP; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Nichols TC; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Li W; Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China., Samulski RJ; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Li C; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Carolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill, NC 27599, USA. |
| Source: | Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2020 Jun 03; Vol. 18, pp. 259-268. Date of Electronic Publication: 2020 Jun 03 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101624857 Publication Model: eCollection Cited Medium: Print ISSN: 2329-0501 (Print) Linking ISSN: 23290501 NLM ISO Abbreviation: Mol Ther Methods Clin Dev Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
